158
Views
8
CrossRef citations to date
0
Altmetric
Brief Report

Screening of ESBL-producing Enterobacteriacae concomitant with low degree of transmission in intensive care and bone marrow transplant units

, , , , , , & show all
Pages 405-409 | Received 24 Oct 2016, Accepted 10 Dec 2016, Published online: 10 Jan 2017

References

  • Zahar JR, Lortholary O, Martin C, et al. Addressing the challenge of extended-spectrum beta-lactamases. Curr Opin Investig Drugs. 2009;10:172–180.
  • European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2015.
  • Petty NK, Ben Zakour NL, Stanton-Cook M, et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci USA. 2014;111:5694–5699.
  • Alves M, Lemire A, Decré D, et al. Extended-spectrum beta-lactamase-producing enterobacteriaceae in the intensive care unit: acquisition does not mean cross-transmission. BMC Infect Dis. 2016;16:147.
  • Vehreschild MJ, Hamprecht A, Peterson L, et al. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies. J Antimicrob Chemother. 2014;69:3387–3392.
  • Hilty M, Betsch BY, Bögli-Stuber K, et al. Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis. 2012;55:967–975.
  • Dziri R, Klibi N, Alonso CA, et al. Detection of CTX-M-15-producing Escherichia coli isolates of lineages ST131-B2 and ST167-A in environmental samples of a Tunisian hospital. Microb Drug Resist. 2016;22:399–403.
  • Guet-Revillet H, Le Monnier A, Breton N, et al. Environmental contamination with extended-spectrum β-lactamases: is there any difference between Escherichia coli and Klebsiella spp? Am J Infect Contr. 2012;40:845–848.
  • Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut (RKI). Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen. [Recommendation of Committee for hospital hygiene and infection prevention (KRINKO) at the Robert Koch Institute (RKI). Hygiene measures for infection or colonization with multidrug-resistant gram-negative bacilli]. Bundesgesundheitsbl. 2012;55:1311–1354.
  • Gröbner S, Linke D, Schütz W, et al. Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase producing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J Med Microbiol. 2009;58:912–922.
  • Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66:4555–4558.
  • Clermont O, Lavollay M, Vimont S, et al. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother. 2008;61:1024–1028.
  • Blanco M, Alonso MP, Nicolas-Chanoine MH, et al. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2009;63:1135–1141.
  • Healy M, Huong J, Bittner T, et al. Microbial DNA typing by automated repetitive-sequence-based PCR. J Clin Microbiol. 2005;43:199–207.
  • Valenza G, Nickel S, Pfeifer Y, et al. Extended-spectrum-β-lactamase-producing Escherichia coli as intestinal colonizers in the German community. Antimicrob Agents Chemother. 2014;58:1228–1230.
  • Valenza G, Nickel S, Pfeifer Y, et al. Prevalence and genetic diversity of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in nursing homes in Bavaria, Germany. Vet Microbiol. 2015;pii:S0378-1135(15)30048-1.
  • Zahar JR, Poirel L, Dupont C, et al. About the usefulness of contact precautions for carriers of extended-spectrum beta-lactamase-producing Escherichia coli. BMC Infect Dis. 2015;15:512.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.